Interview with Aristea Therapeutics CEO James Mackay
Oct 07, 2021•33 min•Season 1Ep. 55
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Aristea is developing drugs for inflammatory diseases, starting with palmoplantar pustulosis. James shares his journey from small town Scotland to big pharma and San Diego
As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:
- Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
- Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
- YouTube https://www.youtube.com/@CareTalkPodcast
- CareTalk website https://www.caretalkpodcast.com/
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.
Episodes through March 2025 were produced by Dafna Williams.
For the best experience, listen in Metacast app for iOS or Android